Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123171) titled 'A randomized controlled trial study on the effects of docosahexaenoic acid (DHA) on cognitive function and ferroptosis biomarkers in the elderly population' on April 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tianjin Medical University
Condition:
Mild cognitive impairment
Intervention:
DHA intervention group:DHA soft capsules 1g/day (1g/capsule, 1 capsule/day)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-07-05
Target Sample Size: DHA intervention group:90;Placebo control group:90;
Countries of Recruitment:
China
To know more, visit h...